首页 | 本学科首页   官方微博 | 高级检索  
检索        

秋水仙碱位点抑制剂的结构特征研究
引用本文:李耀武,周有骏,朱驹,郑灿辉,陈军,唐辉,栗亚男.秋水仙碱位点抑制剂的结构特征研究[J].药学实践杂志,2007,25(6):372-375.
作者姓名:李耀武  周有骏  朱驹  郑灿辉  陈军  唐辉  栗亚男
作者单位:第二军医大学药学院药物化学教研室,上海,200433
摘    要:目的:寻找秋水仙碱结合位点抑制剂的结构特征。方法:将对接得到的8种不同结构抑制剂的结合构象进行叠合匹配,并结合已有的SAR结论来探讨。结果:整个结构由两个疏水基团A、B以及之间的桥链部分组成,但是在空间上A和B必须处于桥链的同侧。A基团的体积以及氢键受体基团的存在对活性有较大影响,B需为平面环且宜连接极性基团以增强结合,而桥链部分可以为1~4个长度的原子但以sp2杂化类型最佳。结论:研究得出的结构特征为设计新的秋水仙碱位点抑制剂提供了直观、简便的参考。

关 键 词:微管  秋水仙碱  药效团  分子对接
文章编号:1006-0111(2007)06-0372-04
收稿时间:2007-09-07
修稿时间:2007年9月7日

Study on the structural features of colchicine-site inhibitors
LI Yao-wu,ZHOU You-jun,ZHU Ju,ZHENG Can-hui,CHEN Jun,TANG Hui and LI Ya-nan.Study on the structural features of colchicine-site inhibitors[J].The Journal of Pharmaceutical Practice,2007,25(6):372-375.
Authors:LI Yao-wu  ZHOU You-jun  ZHU Ju  ZHENG Can-hui  CHEN Jun  TANG Hui and LI Ya-nan
Institution:Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China
Abstract:Objective:To determine the structural features of a set of diverse colchicines-site inhibitors.Methods:The features were revealed by matching the binding conformations generated from docking studies of eight inhibitors,and combined with the available SAR results.Results: The feature is represented as two hydrophobic groups(A and B) and a bridge linked between them,but A and B should be in the same side of the bridge.The volume size and the existence of hydrogen-bond acceptor of group A may have some influence on binding.Group B should be a hydrophobic planar ring,and polar functional group is advantageous.The bridge part could accept 1~4 atoms,but the Sp2 hybrid is welcome.Conclusion:this result may provide useful insights for the design of novel Colchicine-site inhibitors.
Keywords:microtubule  colchicine  pharmacophor  molecular docking
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号